Januvia Jitters: FDA Warns Blockbuster Diabetes Drug May Cause Pancreatitis
This article was originally published in The Pink Sheet Daily
Executive Summary
Scrutiny of Merck’s Januvia could raise more questions about Onglyza and other DPP-4 inhibitors.